Rt Hon JACINDA ARDERN: A couple of things that I would say there: one, testing is one of the things we have to do regularly, but we're also very, very mindful that it is not also a fail-safe mechanism. So it is one thing, and we are, yes, looking to add different testing mechanisms in order to add to the robustness of all of the different filters that we have. In terms of lab capacity, look, there's a little bit of variation in there. My understanding is some of the traditional mechanisms for testing, if you're not doing pooled samples, yes, will use similar capacity as what you might for the processing of nasal PCR tests. However, I can't speak to that in its totality, because I know some of the newer initiatives being brought forward by some of the private sector use a more automated function. So I can't give a final answer, but I'm sure that that is something that the Ministry of Health will discuss with that private sector entity today.